VALN – valneva se - american depositary shares (US:NASDAQ)

News

Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement [Yahoo! Finance]
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
Valneva (NASDAQ:VALN) was downgraded by analysts at Wall Street Zen
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com